Реферат: NASDAQ Biotechnology Index
— американский фондовый индекс. Индекс составляют биотехнологические и фармацевтические компании, чьи акции торгуются на бирже NASDAQ.
Критерии
Критерии включения в NASDAQ Biotechnology Index:
· Компания должна иметь листинг на бирже NASDAQ.
· Компания должна относиться либо к биотехнологической, либо к фармацевтической отрасли.
· Компания не должна быть в процессе банкротства.
· Рыночная капитализация не менее $200 млн.
· Средний ежедневный объём торгов — 100 тысяч акций.
· Акции компании должны котироваться на биржах не менее 6 месяцев
Компоненты
В индекс входят следующие компании:
· Acorda Therapeutics Inc. (NASDAQ: ACOR )
· Adolor Corporation (NASDAQ: ADLR )
· Affymetrix Inc. (NASDAQ: AFFX )
· Akorn Inc. (NASDAQ: AKRX )
· Albany Molecular Research Inc. (NASDAQ: AMRI )
· Alexion Pharmaceuticals Inc. (NASDAQ: ALXN )
· Alexza Pharmaceuticals Inc. (NASDAQ: ALXA )
· Alkermes Inc. (NASDAQ: ALKS )
· Allos Therapeutics Inc. (NASDAQ: ALTH )
· Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY )
· AMAG Pharmaceuticals Inc. (NASDAQ: AMAG )
· Amgen Inc. (NASDAQ: AMGN )
· Amylin Pharmaceuticals Inc. (NASDAQ: AMLN )
· Arena Pharmaceuticals Inc. (NASDAQ: ARNA )
· ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA )
· ArQule Inc. (NASDAQ: ARQL )
· Array BioPharma Inc. (NASDAQ: ARRY )
· Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL )
· BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX )
· Biodel Inc. (NASDAQ: BIOD )
· Biogen Idec Inc. (NASDAQ: BIIB )
· BioMarin Pharmaceutical Inc. (NASDAQ: BMRN )
· BioMimetic Therapeutics Inc. (NASDAQ: BMTI )
· BMP Sunstone Corporation (NASDAQ: BJGP )
· Cadence Pharmaceuticals Inc. (NASDAQ: CADX )
· Cardiome Pharma Corporation (NASDAQ: CRME )
· Celera Corporation (NASDAQ: CRA )
· Celgene Corporation (NASDAQ: CELG )
· Cephalon Inc. (NASDAQ: CEPH )
· Columbia Laboratories Inc. (NASDAQ: CBRX )
· Crucell NV (NASDAQ: CRXL )
· Cubist Pharmaceuticals Inc. (NASDAQ: CBST )
· Cypress Bioscience Inc. (NASDAQ: CYPB )
· Cytokinetics Incorporated (NASDAQ: CYTK )
· Dendreon Corporation (NASDAQ: DNDN )
· DepoMed Inc. (NASDAQ: DEPO )
· Discovery Laboratories Inc. (NASDAQ: DSCO )
· Durect Corporation (NASDAQ: DRRX )
· Dyax Corporation (NASDAQ: DYAX )
· Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP )
· Enzon Pharmaceuticals Inc. (NASDAQ: ENZN )
· Exelixis Inc. (NASDAQ: EXEL )
· Facet Biotech Corporation (NASDAQ: FACT )
· Flamel Technologies S.A. (NASDAQ: FLML )
· Gen-Probe Incorporated (NASDAQ: GPRO )
· Genomic Health Inc. (NASDAQ: GHDX )
· Genzyme Corporation (NASDAQ: GENZ )
· Geron Corporation (NASDAQ: GERN )
· Gilead Sciences Inc. (NASDAQ: GILD )
· GTx Inc. (NASDAQ: GTXI )
· Halozyme Therapeutics Inc. (NASDAQ: HALO )
· Human Genome Sciences Inc. (NASDAQ: HGSI )
· Idenix Pharmaceuticals Inc. (NASDAQ: IDIX )
· Illumina Inc. (NASDAQ: ILMN )
· ImmunoGen Inc. (NASDAQ: IMGN )
· Immunomedics Inc. (NASDAQ: IMMU )
· Impax Laboratories Inc. (NASDAQ: IPXL )
· Incyte Corporation (NASDAQ: INCY )
· Inspire Pharmaceuticals Inc. (NASDAQ: ISPH )
· InterMune Inc. (NASDAQ: ITMN )
· Isis Pharmaceuticals Inc. (NASDAQ: ISIS )
· Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX )
· Life Technologies Corporation (NASDAQ: LIFE )
· Ligand Pharmaceuticals Incorporated (NASDAQ: LGND )
· Luminex Corporation (NASDAQ: LMNX )
· MannKind Corporation (NASDAQ: MNKD )
· Matrixx Initiatives Inc. (NASDAQ: MTXX )
· Maxygen Inc. (NASDAQ: MAXY )
· Medarex Inc. (NASDAQ: MEDX )
· Medivation Inc. (NASDAQ: MDVN )
· Micromet Inc. (NASDAQ: MITI )
· MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK )
· Momenta Pharmaceuticals Inc. (NASDAQ: MNTA )
· Mylan Inc. (NASDAQ: MYL )
· Myriad Genetics Inc. (NASDAQ: MYGN )
· Nabi Biopharmaceuticals (NASDAQ: NABI )
· Nektar Therapeutics (NASDAQ: NKTR )
· Neurocrine Biosciences Inc. (NASDAQ: NBIX )
· Novavax Inc. (NASDAQ: NVAX )
· Noven Pharmaceuticals Inc. (NASDAQ: NOVN )
· NPS Pharmaceuticals Inc. (NASDAQ: NPSP )
· Obagi Medical Products Inc. (NASDAQ: OMPI )
· ONYX Pharmaceuticals Inc. (NASDAQ: ONXX )
· Optimer Pharmaceuticals Inc. (NASDAQ: OPTR )
· Orexigen Therapeutics Inc. (NASDAQ: OREX )
· OSI Pharmaceuticals Inc. (NASDAQ: OSIP )
· Osiris Therapeutics Inc. (NASDAQ: OSIR )
· Pain Therapeutics (NASDAQ: PTIE )
· PDL BioPharma Inc. (NASDAQ: PDLI )
· Perrigo Company (NASDAQ: PRGO )
· Pharmasset Inc. (NASDAQ: VRUS )
· Pozen Inc. (NASDAQ: POZN )
· Progenics Pharmaceuticals Inc. (NASDAQ: PGNX )
· Qiagen N.V. (NASDAQ: QGEN )
· QLT Inc. (NASDAQ: QLTI )
· Questcor Pharmaceuticals Inc. (NASDAQ: QCOR )
· Regeneron Pharmaceuticals Inc. (NASDAQ: REGN )
· Rigel Pharmaceuticals Inc. (NASDAQ: RIGL )
· Salix Pharmaceuticals Ltd. (NASDAQ: SLXP )
· Sangamo BioSciences Inc. (NASDAQ: SGMO )
· Santarus Inc. (NASDAQ: SNTS )
· Savient Pharmaceuticals Inc (NASDAQ: SVNT )
· Seattle Genetics Inc. (NASDAQ: SGEN )
· Sepracor Inc (NASDAQ: SEPR )
· Sequenom Inc. (NASDAQ: SQNM )
· Shire plc (NASDAQ: SHPGY )
· StemCells Inc. (NASDAQ: STEM )
· SuperGen Inc. (NASDAQ: SUPG )
· Synta Pharmaceuticals Corp. (NASDAQ: SNTA )
· Techne Corporation (NASDAQ: TECH )
· Teva Pharmaceutical Industries Limited (NASDAQ: TEVA )
· The Medicines Company (NASDAQ: MDCO )
· Theravance Inc. (NASDAQ: THRX )
· United Therapeutics Corporation (NASDAQ: UTHR )
· Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX )
· ViroPharma Incorporated (NASDAQ: VPHM )
· Vivus Inc. (NASDAQ: VVUS )
· Warner Chilcott Limited (NASDAQ: WCRX )
· XenoPort Inc. (NASDAQ: XNPT )
· XOMA Ltd. (NASDAQ: XOMA )
· ZymoGenetics Inc. (NASDAQ: ZGEN )